drugset / Trial / NCT01193166
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
RandomizedParallel-groupOpen-labelPrevention
Summary
The study will assess the use of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to a protocol-defined treatment failure over 12 months, in patients diagnosed with schizophrenia who were recently released from an inpatient psychiatric hospital.
Timeline
- Start
- 2010-08
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aripiprazole | Other / unclassified | — | Oral |
| Comparator | Haloperidol | Other / unclassified | — | Oral |
| Comparator | Olanzapine | Small molecule | — | Oral |
| Subject | Paliperidone | Unknown | — | Oral |
| Comparator | Perphenazine | Small molecule | — | Oral |
| Comparator | Quetiapine | Small molecule | — | Oral |
| Comparator | Risperidone | Other / unclassified | — | Oral |
| Subject | paliperidone palmitate | Unknown | 78 mg | Other |
| Subject | paliperidone palmitate | Unknown | 117 mg | Other |
| Subject | paliperidone palmitate | Unknown | 156 mg | Other |
| Subject | paliperidone palmitate | Unknown | 234 mg | Other |